Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - herbicide additive | pesticide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | we - acidifier | control of penetration | reduce alkaline hydrolysis | surfactant | to lower ph

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

4 farmers australia pty ltd - non-ionic alcohol ethoxylates - soluble concentrate - non-ionic alcohol ethoxylates emulsifiers & surfactants active 1000.0 g/l - wetting agent - fungicide additive | growth regulator additive | herbicide additive | insecticide additive | pasture topping | water additive | - wetting agent (use as directed) | improve penetrating properties

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - agricultural chemical additive | herbicide additive | wetting agent | activator | penetrant | post emergent herbicide | spray ac - reduce alkaline hydrolysis | tank mixing | wetting agent (use as directed) | additive | agricultural chemical | herbicide | improve penetrating properties | minimise antagonism | spray tank

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - nonionic surfactant blend; ammonium sulphate; vegetable oil ester - water dispersible granule - nonionic surfactant blend emulsifiers & surfactants active 105.0 g/kg; ammonium sulphate ammonium active 572.0 g/kg; vegetable oil ester oil-plant extract active 139.0 g/kg - adjuvant - herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | wetting agent - additive - refer to label | refer to glyphosate 450 g/l label

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

dksh agrisolutions pty ltd - soyal phospholipids; propionic acid - liquid - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - foliar nutrients additive | herbicide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfacta - acidifying surfactant | penetrating surfactant | wetting agent (use as directed) | improve penetrating properties

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

diversey australia pty. limited - soyal phospholipids; propionic acid - dispersible concentrate - soyal phospholipids ungrouped active 350.0 g/l; propionic acid acid-general active 350.0 g/l - surfactant - herbicide additive | pesticide additive | activator | penetrant | post emergent herbicide | spreading adjuvant | surfactant | we - acidifier | control of penetration | reduce alkaline hydrolysis | surfactant | to lower ph

United States - English - NLM (National Library of Medicine)

mckesson corporation dba sky packaging - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 150 mg - propafenone hydrochloride is indicated to: - prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms in patients without structural heart disease. - prolong the time to recurrence of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms in patients without structural heart disease. - treat documented ventricular arrhythmias, such as sustained ventricular tachycardia that, in the judgment of the physician, are life-threatening. initiate treatment in the hospital. usage considerations: - the use of propafenone hydrochloride tablets in patients with permanent atrial fibrillation (af) or in patients exclusively with atrial flutter or psvt has not been evaluated. do not use propafenone hydrochloride tablets to control ventricular rate during af. - some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the 

United States - English - NLM (National Library of Medicine)

a-s medication solutions - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 225 mg - propafenone hydrochloride is indicated to: - prolong the time to recurrence of paroxysmal atrial fibrillation/flutter (paf) associated with disabling symptoms in patients without structural heart disease. - prolong the time to recurrence of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms in patients without structural heart disease. - treat documented ventricular arrhythmias, such as sustained ventricular tachycardia that, in the judgment of the physician, are life-threatening. initiate treatment in the hospital. usage considerations: - the use of propafenone hydrochloride tablets in patients with permanent atrial fibrillation (af) or in patients exclusively with atrial flutter or psvt has not been evaluated. do not use propafenone hydrochloride tablets to control ventricular rate during af. - some patients with atrial flutter treated with propafenone have developed 1:1 conduction, producing an increase in ventricular rate. concomitant treatment with drugs that increase the 

United States - English - NLM (National Library of Medicine)

a-s medication solutions - propafenone hydrochloride (unii: 33xch0hocd) (propafenone - unii:68iqx3t69u) - propafenone hydrochloride 225 mg - propafenone hydrochloride tablets are indicated to: usage considerations: propafenone hydrochloride tablets are contraindicated in the following circumstances: pregnancy category c. there are no adequate and well-controlled studies in pregnant women. propafenone hydrochloride tablets should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus. animal data: teratogenic effects: propafenone has been shown to be embryotoxic (decreased survival) in rabbits and rats when given in oral maternally toxic doses of 150 mg/kg day (about 3 times the maximum recommended human dose [mrhd] on a mg/m2 basis) and 600 mg/kg/day (about 6 times the mrhd on a mg/m2 basis), respectively. although maternally tolerated doses (up to 270 mg/kg/day, about 3 times the mrhd on a mg/m2 basis) produced no evidence of embryotoxicity in rats, post-implantation loss was elevated in all rabbit treatment groups (doses as low as 15 mg/kg/day, about 1/3 the mrhd on a mg/m2 basis). non-teratogenic

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

adama australia pty limited - nonyl phenol ethylene oxide - aqueous concentrate - nonyl phenol ethylene oxide emulsifiers & surfactants active 600.0 g/l - wetting agent - agricultural chemical additive | fungicide additive | herbicide additive | insecticide additive | activator | additive | penetra - spreader spray (refer to directions) | wetting agent (use as directed) | improve penetrating properties